Moolec Science (MLEC)
NASDAQ:MLEC
Want to see MLEC full AI Analyst Report?
MLEC Stock Chart & Stats
$8.93
-$0.04(-4.25%)
At close: 4:00 PM EST
$8.93
-$0.04(-4.25%)
Day’s Range― - ―
52-Week Range$3.08 - $133.50
Previous CloseN/A
Volume11.69K
Average Volume (3M)209.37K
Market Cap
$5.35M
Enterprise Value$251.75M
Total Cash (Recent Filing)$1.93M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,118
10 Day Avg. Volume506,476
30 Day Avg. Volume209,369
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.12
P/FCF Ratio-1.35
Enterprise Value/Market Cap47.08
Enterprise Value/Revenue32.14
Enterprise Value/Gross Profit-393.68
Enterprise Value/Ebitda-48.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercial TractionA very large FY2025 revenue ramp and a jump in gross margin to ~34% signal the business is moving from development toward commercial sales. That indicates growing product-market fit and unit economics that, if sustained, support scalable ingredient sales and partner commercialization over 2-6 months.
Restored Listing ComplianceRegaining Nasdaq compliance via equity improvements and capital injections reduces near-term delisting risk and preserves market access. That structural fix enhances the company’s ability to raise capital, secure partner contracts, and execute commercialization plans without immediate regulatory distraction.
Controlling Shareholder SupportA new majority owner with deep agri focus centralizes decision-making and can provide strategic capital, industry relationships, and aligned execution. That ownership consolidation materially increases the odds of sustained funding and faster commercialization in seed-to-ingredient scaling.
Bears Say
Cash BurnSustained negative operating and free cash flow shows the company still relies on external financing to fund operations and scale production. Persistent cash burn constrains runway, forces dilutive financings or costly debt, and heightens execution risk for multi‑stage commercialization over the medium term.
Elevated Leverage ProfileA materially weakened capital structure and high borrowings raise refinancing and solvency risk, limiting strategic flexibility. Even with recent equity improvements, significant debt and historically negative equity constrain investment in scale-up, making long-term partnerships and supply‑chain expansion more conditional.
Operating Profitability GapLarge accounting losses and continued negative operating profit indicate the cost base and R&D/scale-up expenses still outpace revenues. Without clear path to sustained positive margins, profitability depends on successful scale, cost control, and partner commercialization, which remain uncertain medium-term.
Moolec Science News
MLEC FAQ
What was Moolec Science’s price range in the past 12 months?
Moolec Science lowest stock price was $3.08 and its highest was $133.50 in the past 12 months.
What is Moolec Science’s market cap?
Moolec Science’s market cap is $5.35M.
When is Moolec Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Moolec Science’s earnings last quarter?
Currently, no data Available
Is Moolec Science overvalued?
According to Wall Street analysts Moolec Science’s price is currently Overvalued.
Does Moolec Science pay dividends?
Moolec Science does not currently pay dividends.
What is Moolec Science’s EPS estimate?
Moolec Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Moolec Science have?
Moolec Science has 726,118 shares outstanding.
What happened to Moolec Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Moolec Science?
Currently, no hedge funds are holding shares in MLEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Moolec Science
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Technical Analysis
AIM ImmunoTech
―
Ensysce Biosciences
―
Cyclerion Therapeutics
―
―
Calidi Biotherapeutics
―
Ownership Overview
―
Insiders
0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---